**AI医学成像新星AZmed获1500万欧元A轮融资，引领医疗科技革新**
法国医疗科技初创公司AZmed近日宣布，成功完成了一笔1500万欧元的A轮融资，投资方包括Maison Worms、Techstars和Tempact Ventures等知名机构。此轮融资将助力AZmed进一步推动其人工智能医学成像软件的发展，为全球医疗行业带来颠覆性的改变。
AZmed的核心产品是名为Rayvolve的AI软件，该软件专为诊断辅助设计，能够识别标准放射照相中的多种异常情况。这一创新技术旨在优化放射科医生和急诊医生的工作流程，显著节省他们在图像解读上的时间，同时降低由于人为错误导致的诊断失误风险，从而提高医疗服务的质量和效率。
据Tech.eu报道，AZmed的Rayvolve软件利用先进的机器学习算法，能够自动检测和标记可能的病变，为医生提供快速而准确的初步分析。这一创新解决方案有望减轻医疗专业人士的工作负担，让更多患者能够及时得到准确的诊断和治疗。
AZmed的A轮融资不仅是对其技术实力的认可，也是对AI在医疗领域应用前景的看好。随着这笔资金的注入，公司计划扩大研发团队，加速产品的临床验证，并在全球范围内拓展市场，将Rayvolve带给更多医疗机构和患者，推动全球医疗健康领域的智能化进程。
英语如下：
**AI Medical Imaging Startup AZmed Secures €15M in Funding, Revolutionizing Diagnostic Efficiency**
Keywords: AI medical imaging, AZmed fundraising, Rayvolve software
News Content: **AI medical imaging pioneer AZmed raises €15 million in Series A, transforming healthcare technology**
French healthcare technology startup AZmed has recently announced a successful €15 million Series A funding round, backed by prominent investors such as Maison Worms, Techstars, and Tempact Ventures. This financing will fuel the company’s advancement in artificial intelligence (AI) medical imaging software, poised to disrupt the global healthcare industry.
At the heart of AZmed’s offering is its Rayvolve AI software, specifically designed for diagnostic assistance, capable of identifying multiple abnormalities in standard radiographs. The technology aims to streamline radiologists’ and emergency physicians’ workflows, significantly reducing time spent on image interpretation and minimizing the risk of misdiagnosis due to human error, thereby enhancing the quality and efficiency of healthcare services.
According to Tech.eu, AZmed’s Rayvolve employs advanced machine learning algorithms to automatically detect and flag potential abnormalities, providing doctors with rapid and accurate preliminary analyses. This innovative solution promises to alleviate the workload of medical professionals, enabling more patients to receive timely and accurate diagnoses and treatments.
AZmed’s Series A funding not only validates its technological prowess but also signals a strong belief in the potential of AI in healthcare. With this injection of capital, the company intends to expand its research and development team, accelerate clinical validation of its products, and broaden its market reach globally, bringing Rayvolve to more healthcare institutions and patients, thereby propelling the global healthcare sector’s智能化进程.
【来源】https://tech.eu/2024/02/20/french-medtech-azmed-raises-eur15m/
Views: 2